Center for Financial Planning Inc. Has $239,000 Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Center for Financial Planning Inc. increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 77.5% during the fourth quarter, Holdings Channel reports. The fund owned 458 shares of the medical equipment provider’s stock after acquiring an additional 200 shares during the quarter. Center for Financial Planning Inc.’s holdings in Intuitive Surgical were worth $239,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in ISRG. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $26,000. Godsey & Gibb Inc. lifted its position in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical in the 3rd quarter worth approximately $33,000. Decker Retirement Planning Inc. purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $36,000. Finally, Capital Performance Advisors LLP purchased a new stake in Intuitive Surgical in the 3rd quarter worth approximately $38,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG opened at $595.55 on Friday. The company has a market capitalization of $212.12 billion, a PE ratio of 92.91, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The company’s fifty day moving average price is $558.58 and its 200 day moving average price is $518.00.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Barclays increased their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Truist Financial increased their target price on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. CICC Research assumed coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They set a “neutral” rating and a $550.00 price target on the stock. Finally, BTIG Research raised their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Insider Buying and Selling

In other Intuitive Surgical news, CFO Jamie Samath sold 188 shares of the firm’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $101,332.00. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,720,023. This trade represents a 2.10 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 6,348 shares of company stock worth $3,587,582 in the last quarter. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.